Vertex Pharmaceuticals Inc. buy The Goldman Sachs Group, Inc.
Start price
31.01.24
/
50%
€397.35
Target price
31.01.25
€515.17
Performance (%)
11.04%
End price
01.02.25
€441.20
Summary
This prediction ended on 01.02.25 with a price of €441.20. The prediction had a final performance of 11.04%. The_Goldman_Sachs_Gr has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -19.493% | -19.493% | -24.420% |
| iShares Core DAX® | 0.683% | 0.785% | 38.055% |
| iShares Nasdaq 100 | -1.457% | 3.734% | 23.153% |
| iShares Nikkei 225® | 0.931% | 2.958% | 11.220% |
| iShares S&P 500 | -2.022% | 2.444% | 15.543% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $442.00 to $559.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by The_Goldman_Sachs_Gr for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€382.55
07.05.25
07.05.25
-
07.05.26
07.05.26
-14.80%
12:07
12:07
